Ignite Creation Date:
2025-12-26 @ 11:46 AM
Ignite Modification Date:
2026-04-24 @ 7:04 AM
Study NCT ID:
NCT01429116
Status:
COMPLETED
Last Update Posted:
2015-04-21
First Post:
2011-08-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception
Sponsor:
Vanda Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
VP-VEC-162-3204
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None